1. Stock Analysis
  2. 3722
Back to Stock Analysis

Novo Nordisk$NVO

8 research articles

Research Articles

Stock of the Week: Novo Nordisk - A Possible Inflection Point, Powered by Oral Therapies

By Quality Stocks • 2026-01-15T12:43:16.103Z

Novo Nordisk ($NVO): A Quality Investing Deep Dive into the GLP-1 Leader's Long-Term Potential and Risks

By Compound & Fire • 2025-11-18T16:11:52.905Z

Novo Nordisk, Miracle Drug Creator?

By Quality Stocks • 2024-01-27T12:30:53.944Z

Eli Lilly vs Novo Nordisk: a Stock Duel

By Quality Stocks • 2024-10-13T11:49:41.309Z

Stock of the Week: Novo Nordisk

By Quality Stocks • 2025-02-13T12:27:20.940Z

Stock of the Week - Novo Nordisk: A Fall from Grace Hiding Untapped Opportunities?

By Quality Stocks • 2025-08-12T10:53:19.371Z

Novo Nordisk - 9 years later

By Value and Opportunity • 2025-08-01T14:46:18.189Z

Novo Nordisk - 9 years later

By Value and Opportunity • 2025-08-01T14:46:18.189Z

RhinoInvestory LogoRhinoInvestory

Navigation

  • Newsletters
  • Stock Analysis
  • Tools
  • Hedge Fund Letters
  • Podcasts
  • Books
  • DataRoma Alternatives
  • Famous Investor Letters
  • Value Investing Resources

Browse Stock Analysis

  • By Company
  • By Analyst
  • By Sector
  • By Country
  • By Ticker

Free Tools

  • Compound Interest Calculator
  • CAGR Calculator
  • Stock Profit Calculator
  • Rule of 72 Calculator
  • Dividend Calculator
  • DCF Calculator
  • Position Size Calculator

Connect

© 2026 RhinoInvestory. All rights reserved.